Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (DFPH) Treasury Shares (2020 - 2025)

Historic Treasury Shares for Oncology Institute (DFPH) over the last 3 years, with Q3 2025 value amounting to $1.0 million.

  • Oncology Institute's Treasury Shares changed 0.0% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.0 million for FY2024, which is 0.0% changed from last year.
  • Per Oncology Institute's latest filing, its Treasury Shares stood at $1.7 million for Q3 2025, which was up 1861.52% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Oncology Institute's Treasury Shares peaked at $3.6 million during Q1 2023, and registered a low of $1.4 million during Q2 2021.
  • In the last 5 years, Oncology Institute's Treasury Shares had a median value of $1.7 million in 2023 and averaged $1.9 million.
  • The largest annual percentage gain for Oncology Institute's Treasury Shares in the last 5 years was 1398.21% (2024), contrasted with its biggest fall of 0.0% (2024).
  • Over the past 3 years, Oncology Institute's Treasury Shares (Quarter) stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $1.0 million for Q2 2025, and $1.0 million during Q1 2025.